M D I Vergouwen1, D Backes2,3, I C van der Schaaf4, J Hendrikse4, R Kleinloog5, A Algra2, G J E Rinkel2,6. 1. From the Department of Neurology and Neurosurgery (M.D.I.V., D.B., A.A., G.J.E.R.) m.d.i.vergouwen@umcutrecht.nl. 2. From the Department of Neurology and Neurosurgery (M.D.I.V., D.B., A.A., G.J.E.R.). 3. Department of General Practice (D.B.), Erasmus Medical Center, Rotterdam, the Netherlands. 4. Brain Center Rudolf Magnus, Department of Radiology (I.C.v.d.S., J.H.). 5. Department of Neurology (R.K.), Academic Medical Center, Amsterdam, the Netherlands. 6. Julius Center for Health Sciences and Primary Care, (G.J.E.R.), University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Abstract
BACKGROUND AND PURPOSE: Previous studies have suggested that gadolinium enhancement of the wall of unruptured intracranial aneurysms on MR imaging may reflect aneurysm wall instability. However, all previous studies were cross-sectional. In this longitudinal study, we investigated whether aneurysm wall enhancement is associated with an increased risk of aneurysm instability. MATERIALS AND METHODS: We included all patients 18 years of age or older with ≥1 unruptured aneurysm from the University Medical Center Utrecht, the Netherlands, who were included in 2 previous studies with either 3T or 7T aneurysm wall MR imaging and for whom it was decided not to treat the aneurysm but to monitor it with follow-up imaging. We investigated the risk of growth or rupture during follow-up of aneurysms with and without gadolinium enhancement of the aneurysm wall at baseline and calculated the risk difference between the 2 groups with corresponding 95% confidence intervals. RESULTS: We included 57 patients with 65 unruptured intracranial aneurysms. After a median follow-up of 27 months (interquartile range, 20-31 months), growth (n = 2) or rupture (n = 2) was observed in 4 of 19 aneurysms (21%; 95% CI, 6%-54%) with wall enhancement and in zero of 46 aneurysms (0%; 95% CI, 0%-8%) without enhancement (risk difference, 21%; 95% CI, 3%-39%). CONCLUSIONS: Gadolinium enhancement of the aneurysm wall on MR imaging is associated with an increased risk of aneurysm instability. The absence of wall enhancement makes it unlikely that the aneurysm will grow or rupture in the short term. Larger studies are needed to investigate whether aneurysm wall enhancement is an independent predictor of aneurysm instability.
BACKGROUND AND PURPOSE: Previous studies have suggested that gadolinium enhancement of the wall of unruptured intracranial aneurysms on MR imaging may reflect aneurysm wall instability. However, all previous studies were cross-sectional. In this longitudinal study, we investigated whether aneurysm wall enhancement is associated with an increased risk of aneurysm instability. MATERIALS AND METHODS: We included all patients 18 years of age or older with ≥1 unruptured aneurysm from the University Medical Center Utrecht, the Netherlands, who were included in 2 previous studies with either 3T or 7T aneurysm wall MR imaging and for whom it was decided not to treat the aneurysm but to monitor it with follow-up imaging. We investigated the risk of growth or rupture during follow-up of aneurysms with and without gadolinium enhancement of the aneurysm wall at baseline and calculated the risk difference between the 2 groups with corresponding 95% confidence intervals. RESULTS: We included 57 patients with 65 unruptured intracranial aneurysms. After a median follow-up of 27 months (interquartile range, 20-31 months), growth (n = 2) or rupture (n = 2) was observed in 4 of 19 aneurysms (21%; 95% CI, 6%-54%) with wall enhancement and in zero of 46 aneurysms (0%; 95% CI, 0%-8%) without enhancement (risk difference, 21%; 95% CI, 3%-39%). CONCLUSIONS:Gadolinium enhancement of the aneurysm wall on MR imaging is associated with an increased risk of aneurysm instability. The absence of wall enhancement makes it unlikely that the aneurysm will grow or rupture in the short term. Larger studies are needed to investigate whether aneurysm wall enhancement is an independent predictor of aneurysm instability.
Authors: Rachel Kleinloog; Emine Korkmaz; Jaco J M Zwanenburg; Hugo J Kuijf; Fredy Visser; Roos Blankena; Jan A Post; Ynte M Ruigrok; Peter R Luijten; Luca Regli; Gabriel J E Rinkel; Bon H Verweij Journal: Neurosurgery Date: 2014-12 Impact factor: 4.654
Authors: Daan Backes; Gabriel J E Rinkel; Jacoba P Greving; Birgitta K Velthuis; Yuichi Murayama; Hiroyuki Takao; Toshihiro Ishibashi; Michiya Igase; Karel G terBrugge; Ronit Agid; Juha E Jääskeläinen; Antti E Lindgren; Timo Koivisto; Mikael von Und Zu Fraunberg; Shunji Matsubara; Junta Moroi; George K C Wong; Jill M Abrigo; Keiji Igase; Katsumi Matsumoto; Marieke J H Wermer; Marianne A A van Walderveen; Ale Algra; Mervyn D I Vergouwen Journal: Neurology Date: 2017-03-31 Impact factor: 9.910
Authors: S Nagahata; M Nagahata; M Obara; R Kondo; N Minagawa; S Sato; S Sato; W Mouri; S Saito; T Kayama Journal: Clin Neuroradiol Date: 2014-10-21 Impact factor: 3.649
Authors: Jacoba P Greving; Marieke J H Wermer; Robert D Brown; Akio Morita; Seppo Juvela; Masahiro Yonekura; Toshihiro Ishibashi; James C Torner; Takeo Nakayama; Gabriël J E Rinkel; Ale Algra Journal: Lancet Neurol Date: 2013-11-27 Impact factor: 44.182
Authors: Matthew T Bender; Haley Wendt; Thomas Monarch; Narlin Beaty; Li-Mei Lin; Judy Huang; Alexander Coon; Rafael J Tamargo; Geoffrey P Colby Journal: Neurosurgery Date: 2018-10-01 Impact factor: 4.654
Authors: Annemijn M Algra; Antti Lindgren; Mervyn D I Vergouwen; Jacoba P Greving; Irene C van der Schaaf; Tristan P C van Doormaal; Gabriel J E Rinkel Journal: JAMA Neurol Date: 2019-03-01 Impact factor: 18.302
Authors: Rob Molenberg; Marlien W Aalbers; Auke P A Appelman; Maarten Uyttenboogaart; J Marc C van Dijk Journal: Eur J Neurol Date: 2021-08-25 Impact factor: 6.288
Authors: C J H C M van Laarhoven; M L Rots; V E C Pourier; N K N Jorritsma; T Leiner; J Hendrikse; M D I Vergouwen; G J de Borst Journal: AJNR Am J Neuroradiol Date: 2020-02-27 Impact factor: 3.825
Authors: Jorge A Roa; Mario Zanaty; Daizo Ishii; Yongjun Lu; David K Kung; Robert M Starke; James C Torner; Pascal M Jabbour; Edgar A Samaniego; David M Hasan Journal: J Neurosurg Date: 2020-03-06 Impact factor: 5.115
Authors: S Hadad; F Mut; B J Chung; J A Roa; A M Robertson; D M Hasan; E A Samaniego; J R Cebral Journal: AJNR Am J Neuroradiol Date: 2020-12-24 Impact factor: 3.825